跳至主要内容
临床试验/NL-OMON44204
NL-OMON44204已完成不适用

ChanGes In Right ventricular volumes And Function Following diurEtic Treatment In Pulmonary arterial hypertension patients with decompensated right heart failure (GIRAFFE) - Changes in right ventricular volumes and function

Vrije Universiteit0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Diagnosis of idiopathic PAH, hereditary PAH, drug- and toxins induced PAH or chronic thrombo-embolic PH (CTEPH), according to ESC/ERS pulmonary hypertension guidelines (15)
  • - Symptoms of decompensated right heart failure (ankle edema, ascites, weight gain) based on the assessment and the evaluation of the pulmonologist for which an up-titration of the diuretics is indicated
  • - Age >=18 and <=80 years
  • - Able to understand and willing to sign the Informed Consent Form

排除标准

  • - Pregnant subjects
  • - Claustrophobia
  • - Inability to provide informed consent
  • - Change in PAH specific therapy during or the 3 months before the up-titration of diuretics
  • - Change in (dose) of any other medication.
  • - One or more of the following co-morbidities:, uncontrolled systemic hypertension (>140/90 mmHg) , renal failure (eGFR <30), recent diagnosis of pulmonary embolism (within 6 months).
  • - Contraindication for CMR imaging:
  • o Claustrophobia
  • o Implanted cardiac defibrillator or pacemaker
  • o Cochlear implant
  • - PH of any cause other than permitted in the entry criteria
  • - Known history of noncompliance considering therapies

研究者

相似试验